Use in First In Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry
Use in First In Human Clinical Trials to Expedite Development of Oncology Drugs and Biologics Guidance for Industry guidance is to provide advice to…
Read more →Inclusion of Older Adults in Cancer Clinical Trials
Inclusion of Older Adults in Cancer Clinical Trials guidance provides recommendations regarding the inclusion of older adult patients in clinical trials of drugs for…
Read more →Bioavailability Studies Submitted in NDAs or INDs General Considerations
Bioavailability Studies Submitted in NDAs or INDs General Considerations guidance provides recommendations to sponsors and applicants2 submitting bioavailability (BA) information for drug products in…
Read more →Electronic Submission of IND Safety Reports Technical Conformance Guide
Electronic Submission of IND Safety Reports Technical Conformance Guide Technical Conformance Guide (Guide) provides specifications, recommendations, and general considerations on how to submit electronic…
Read more →E2B(R3) The Electronic Transmission of Individual Case Safety Reports Implementation Guide Appendix to the Implementation Guide Backwards and Forwards Compatibility
E2B(R3) The Electronic Transmission of Individual Case Safety Reports Implementation Guide Appendix to the Implementation Guide Backwards and Forwards Compatibility document is an appendix…
Read more →Advanced Prostate Cancer: Developing Gonadotropin Releasing Hormone Analogues Guidance for Industry
Advanced Prostate Cancer: Developing Gonadotropin Releasing Hormone Analogues Guidance for Industry guidance describes the Food and Drug Administration’s (FDA’s) current recommendations regarding the overall…
Read more →